Related Experiment Videos
Revisiting methylprednisolone aceponate: efficacy, safety and current positioning
Jaime Piquero-Casals1, Raul De Lucas2, Juan Francisco Mir-Bonafé3
1Department of Aesthetic Dermatology and Laser, Dermacentric Health & Aesthetics, Barcelona, Spain.
Background:
Topical corticosteroids are essential for the management of inflammatory skin diseases but optimizing efficacy whilst minimizing adverse effects remains critical. Methylprednisolone aceponate (MPA) is a fourth-generation, non-halogenated corticosteroid developed to enhance local activity with limited systemic exposure. This review summarizes its pharmacology, clinical efficacy and safety.
Methods:
A PubMed search (1990-2025) was conducted to identify relevant studies on MPA in inflammatory dermatoses.
Results:
MPA's di-esterified structure and 6α-methyl modification provide potent anti-inflammatory activity with low atrophogenic potential. It is activated within the skin to a highly active metabolite and rapidly inactivated systemically, resulting in minimal systemic absorption. Clinically, MPA provides rapid pruritus relief and high clearance rates in eczematous conditions, including atopic, contact and seborrheic dermatitis. Once-daily application is generally sufficient, supporting adherence. Its availability in multiple formulations allows treatment to be tailored to lesion type and anatomical site. Long-term use is associated with a low risk of skin atrophy or hypothalamic-pituitary-adrenal axis suppression, and allergic sensitization is rare.
Conclusions:
MPA offers an effective and well-tolerated option for acute and maintenance management of inflammatory skin diseases.
Related Concept Videos
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Pericarditis III: Medical Management
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
COPD: Management Using Bronchodilators and Corticosteroids
Myocarditis III: Medical Management
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...